L
Founded 2011, Oxford-based VC. Manages 3 enterprise capital funds incl. £30m Oxford Technology ECF & £40m Longwall Ventures ECF (c.£70m AUM). 4 team (3 partners): David Denny, Matthew Frohn, Jane CFO. 47+ portfolio investments. Notable: OrganOx (therapeutic devices), Wayland Additive (3D printing), Helio Display Materials, Biofidelity, Kinomica. 2 exits incl. OrganOx IPO.
Check Size
£250K - £2M
Investment Focus
Investment Thesis
Deep tech, life sciences, physical sciences. Seed & Series A across UK science spinouts & university-derived companies. Focus on health, resilience, sustainability. £250k-£2m typical cheques. Co-invests frequently w/ Oxford University Innovation, Parkwalk, BGF. Avoids late-stage/pure software.
Interested in connecting?
Visit their website or reach out directly.